If this study comes out positive for Axiron, then I think that...

If this study comes out positive for Axiron, then I think that we can expect a big increase in the numbers of doctors prescribing Axiron.

Indeed it should be enough to offset the labelling issues of the FDA. A US doctor's first priority is always to ensure that he doesn't get sued, patient outcomes are a distant second.

With the most recent credible peer reviewed study backing up Axiron, it is reasonable to expect that some doctors will be more inclined to prescribe it.

And this doesn't mention the fact that Lily will doubtless follow up the study with some marketing spend to win over patients' hearts and minds.